Skip to content
Home  /  FRANZCP  /  Study notes  /  Sexual disorders and gender dysphoria

Sexual disorders and gender dysphoria

● FRANZCP LO RANZCP_S2_A15.11LO RANZCP_S2_C5.3 3,101 words
Free preview. This study note covers 2 learning objectives (RANZCP_S2_A15.11, RANZCP_S2_C5.3) from the FRANZCP curriculum. Inside PRIMEX you get AI-graded SAQ practice on this topic, MCQs across the full syllabus, and a curriculum tracker that ticks off every learning objective.

Overview

ICD-11 similarly replaced the ICD-10 section "Disorders of Sexual Preference" with "Paraphilic Disorders," reflecting a parallel shift away from pathologising unconventional sexuality per se toward defining disordered or harmful sexual behaviour.


Epidemiology

Paraphilic disorders are predominantly identified in male clinical and forensic populations, though this likely reflects ascertainment bias rather than a true sex difference in prevalence.

Key epidemiological findings:


Aetiology and Pathophysiology

The aetiology of paraphilias remains incompletely understood; both biological and psychosocial factors are implicated.

Biological Factors

Psychosocial Factors

Comorbidity

Comorbid Category Examples
Mood disorders Major depressive disorder, bipolar disorder
Anxiety disorders Social anxiety disorder
Personality disorders Antisocial, narcissistic, psychopathic features most strongly associated
Substance use disorders Alcohol, stimulant use disorders
Neurodevelopmental disorders ADHD, intellectual disability
Other paraphilic disorders High crossover rates across subtypes

Classification and Diagnostic Criteria

DSM-5-TR Paraphilic Disorders

Disorder Core Focus of Deviant Arousal
Voyeuristic disorder Observing unsuspecting persons who are naked, disrobing, or engaged in sexual activity
Exhibitionistic disorder Exposing genitals to an unsuspecting person
Frotteuristic disorder Touching or rubbing against a non-consenting person
Sexual masochism disorder Being humiliated, beaten, bound, or made to suffer
Sexual sadism disorder Inflicting physical or psychological suffering on another person
Pedophilic disorder Sexual focus on prepubescent children (generally ≤13 years); diagnosable from age ≥16 with victim at least 5 years younger
Fetishistic disorder Non-living objects or specific non-genital body parts
Transvestic disorder Sexually arousing cross-dressing
Other specified / unspecified paraphilic disorder Clinically significant presentations not captured above (e.g. necrophilia, zoophilia, urophilia, coprophilia)

Diagnostic Framework

Criterion A (paraphilia): Intense and persistent sexual arousal to the specified stimulus, manifested by fantasies, urges, or behaviours, present for at least 6 months.

Criterion B (paraphilic disorder): The individual has acted on these urges with a non-consenting person, OR the urges or fantasies cause clinically significant distress or impairment in social, occupational, or other areas of functioning.

Course Specifiers (DSM-5-TR)

Specifiers apply to most paraphilic disorders, with three exceptions: pedophilic disorder, other specified paraphilic disorder, and unspecified paraphilic disorder.

Specifier Meaning
In a controlled environment Absence of paraphilic urges in a setting that restricts opportunities to act on them
In full remission No acting on urges with a non-consenting person AND no distress or impairment for ≥5 years while in an uncontrolled environment

ICD-11 Classification

Paraphilia-Related Disorders and Hypersexual Disorder

Key points:


Assessment

Clinical Psychiatric Evaluation

A comprehensive evaluation includes:

Objective Assessments

Given the reluctance of individuals with paraphilic disorders to self-disclose, objective assessments are important adjuncts:

Instrument Description Setting
Penile plethysmography (phallometry) Measures penile circumference change in response to audiovisual stimuli Specialist forensic; identifies sexual interest profile independent of self-report; also used to monitor treatment response
Visual reaction time (VRT) Measures viewing time for images of persons of varying age and sex Non-invasive index of sexual interest
Sexual history polygraph Physiological responses during structured interview More common in mandated treatment programs than routine clinical settings; not diagnostic in isolation

Psychological testing has no established diagnostic role in paraphilic disorders.

Risk Assessment Tools

Tool Type Focus
Static-99R Actuarial Static risk factors for sexual reoffending
SVR-20 Structured professional judgement (SPJ) Sexual violence risk, static and dynamic
RSVP SPJ Comprehensive sexual violence risk
STABLE-2007 / ACUTE-2007 Dynamic actuarial Changeable risk factors; used alongside Static-99R

Differential Diagnosis

Diagnosis Distinguishing Features
Paraphilic interest (not disorder) Intense sexual interest without distress, impairment, or harm to others, not a mental disorder
OCD Intrusive sexual thoughts experienced as ego-dystonic; no arousal component; responds to SRI treatment
Major depressive disorder / bipolar disorder Hypersexual behaviour or unusual sexual interests secondary to mood episode; resolves with mood stabilisation
Psychotic disorder Sexual behaviours emerging in context of active psychosis; not a paraphilic disorder if temporally linked to psychotic episode
CSBD (ICD-11) Repetitive difficult-to-control sexual behaviour; not necessarily paraphilic; recognised in ICD-11 but absent from DSM-5-TR
Neurodegenerative / acquired neurological disorder New-onset disinhibited or paraphilic-appearing behaviour (frontotemporal dementia, TBI, Huntington disease, Parkinson disease on dopaminergic therapy), represents a neurological phenomenon, not a primary paraphilic disorder
Antisocial personality disorder Sexual offending without paraphilia; opportunistic rather than driven by deviant arousal

Management

Pharmacological Treatment

The stepwise model moves from less to more potent agents based on clinical severity and risk:

$$\text{SSRIs} \rightarrow \text{oral antiandrogens} \rightarrow \text{depot GnRH agonists}$$

SSRIs and Serotonergic Agents

Drug Dose Range Notes
Sertraline 50-200 mg/day Standard first-line choice
Fluoxetine 20-80 mg/day Alternative first-line
Fluvoxamine 100-300 mg/day Preferred where OCD-spectrum features are prominent

Antiandrogen and Hormonal Agents

Drug Mechanism Route / Dose Monitoring
Medroxyprogesterone acetate (MPA) Progestogen; suppresses LH/FSH; reduces testosterone Oral 60-150 mg/day or IM depot LFTs, lipids, weight, bone density, glucose
Cyproterone acetate (CPA) Androgen receptor antagonist + progestogen; suppresses LH Oral 50-200 mg/day or IM depot LFTs, adrenal function, cardiovascular
Leuprorelin (GnRH agonist) Initial LH flare then sustained suppression → castrate testosterone levels SC/IM depot monthly or 3-monthly Testosterone, DEXA, metabolic parameters
Triptorelin (GnRH agonist) Same mechanism as leuprorelin IM depot 3-monthly As for leuprorelin

Psychological Interventions

Cognitive-Behavioural Therapy (CBT)

The most evidence-supported psychological approach. Key components:

Strength-Based Rehabilitation Models

Current evidence-based programs favour these approaches:

Model Core Principle
Good Lives Model (GLM) Identifies offenders' primary human goods; develops prosocial means to achieve them; addresses underlying needs driving offending
Risk-Need-Responsivity (RNR) Model Treatment intensity matched to risk level; targets criminogenic needs; delivery adapted to offender learning style

Behavioural Techniques

Technique Description
Aversion conditioning Pairing paraphilic stimuli with aversive stimuli (olfactory or electrical); classical conditioning to extinguish arousal
Covert sensitisation Imaginal pairing of paraphilic fantasy with aversive imagery
Masturbatory reconditioning Directing masturbatory fantasy toward non-paraphilic stimuli
Imaginal desensitisation Repeated non-reinforced imaginal exposure to reduce arousal responses

Social and Community Interventions


Prognosis


Special Populations

Adolescents

Older Adults

Neurodevelopmental Disorders


Medicolegal and Ethical Considerations

Civil Commitment of Sexually Dangerous Persons

In Australia, all states and territories have legislation enabling post-sentence preventive detention or extended supervision orders for high-risk sex offenders:

Jurisdiction Legislation
Queensland Dangerous Prisoners (Sexual Offenders) Act 2003
Victoria Serious Sex Offenders (Detention and Supervision) Act 2009
Western Australia Dangerous Sexual Offenders Act 2006
New South Wales High Risk Offenders Act 2017

Fitness and Criminal Responsibility

Confidentiality and Mandatory Reporting

Castration: Surgical and Chemical

Informed Consent and Coerced Treatment

Therapist Ethics in Sex Offender Treatment


Key Exam Points

Domain High-Yield Fact
DSM-5-TR definition Paraphilia ≠ paraphilic disorder; disorder requires Criterion B (distress/impairment OR harm/risk to others)
Course specifiers "In full remission" requires ≥5 years in uncontrolled environment; specifiers excluded from pedophilic disorder and unspecified categories
ICD-11 Replaced "Disorders of Sexual Preference"; introduced CSBD as separate entity in impulse-control disorders
Hypersexual Disorder Proposed for DSM-5 but rejected; not in DSM-5-TR
Pharmacotherapy sequence SSRIs → oral antiandrogens → depot GnRH agonists
GnRH agonists Require DEXA monitoring, calcium/vitamin D; castrate testosterone levels
Psychological treatment CBT and strength-based models (GLM, RNR) are current standard; relapse prevention models largely superseded
Recidivism Incest offenders recidivate at ~half the rate of extrafamilial child molesters
Paraphilic crossover One paraphilic disorder increases risk of others; crossover across victim type, age, and relationship documented
Late-onset paraphilic behaviour Neurological aetiology must be excluded (FTD, TBI, Huntington, dopaminergic medications)
Objective testing Phallometry does not rely on self-report; also used to monitor treatment response
APA on castration laws "Objectionable… improperly link medical treatment with punishment and social control"
PRIMEX

Practice this topic in the app

Attempt a graded SAQ on this exact LO or work through MCQs that map to RANZCP_S2_A15.11, RANZCP_S2_C5.3. Your free trial covers all 26 exams.

Start 7-day free trial

7-day free trial · Cancel anytime

Quick recall flashcards

A small sample of the deck for this topic. Tap a question to reveal the answer. The full deck and spaced-repetition scheduler live inside PRIMEX.

How does DSM-5-TR classify the main categories of sexual disorders?
  • Sexual dysfunctions (e.g., erectile disorder, female orgasmic disorder, genito-pelvic pain/penetration disorder)
  • Paraphilic disorders (e.g., voyeuristic, exhibitionistic, fetishistic, pedophilic disorder)
  • Gender dysphoria (separate chapter)
  • Note: sexual dysfunction due to substance/medication or another medical condition are specified subtypes
What are the DSM-5-TR male sexual dysfunctions?
  • Erectile disorder
  • Delayed ejaculation
  • Early (premature) ejaculation
  • Male hypoactive sexual desire disorder
  • Substance/medication-induced sexual dysfunction
  • Sexual dysfunction due to another medical condition
What are the DSM-5-TR female sexual dysfunctions?
  • Female sexual interest/arousal disorder
  • Female orgasmic disorder
  • Genito-pelvic pain/penetration disorder (replaced DSM-IV vaginismus and dyspareunia)
  • Substance/medication-induced sexual dysfunction
  • Sexual dysfunction due to another medical condition
What is the minimum duration criterion for most DSM-5-TR sexual dysfunctions?

Symptoms must be present for approximately 6 months or more and cause clinically significant distress in the individual.

Start free trial→